PTC Therapeutics | PTCT - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 34.96B 3.49B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cytokinetics USD 1.21B 369.02M 2026-06
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 12.53B 6.11B 2026-06
Incyte USD 6.03B 542.31M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Xencor USD 523.21M 40.36M 2026-06